Martha Bebinger

Doctors are researching why some patients remain unconscious for days or weeks, even after sedating drugs are withdrawn. They also worry that these patients aren't being given time to recover.

The state offers support and resources for people isolating because of COVID-19 — helping them make choices that keep everyone safe. It's work more states need to fund, experts say.

Nationwide, coronavirus infection numbers are trending down, but several states are seeing upticks, with the heaviest impact falling on communities of color and nursing home residents.

"I know we will succeed somewhat and we will fail somewhat," says one of the plan's chief architects. "We won't be able to find every single person — but we will hopefully prevent a lot of deaths."

As the health industry focuses on COVID-19, there has been a big drop in nonurgent visits for primary care and specialty care. Medical practices are being forced to furlough or lay off staff.

People in recovery from opioid or alcohol addiction are weathering a new storm of depression, anxiety and isolation these days, as 12-step programs move online and detox centers close their doors.

Despite Trump's public remarks, infectious disease experts say it's premature to think hydroxychloroquine will help against COVID-19. And patients with lupus or rheumatoid arthritis rely on the drug.

Some physicians say connecting environmental effects of climate change — heat waves, more pollen and longer allergy seasons — to the health consequences helps them better care for patients.

Overdose deaths involving fentanyl are rising — up 113 percent on average each year from 2013 to 2016. Dealers are adding cheap fentanyl to the illicit drug supply, and some users get it accidentally.

The Massachusetts attorney general alleges that the family behind Purdue Pharma knew that OxyContin was causing overdoses, yet continued to cash in. New documents in the case were released Thursday.